サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1646530

欧州の経腸栄養市場：市場規模と予測 (2021～2031年)、地域シェア、動向、成長機会 - 分析範囲 (製品種類別、国別)

Europe Enteral Nutrition Market Size and Forecast 2021-2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country

出版日
ページ情報
英文 124 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
欧州の経腸栄養市場：市場規模と予測 (2021～2031年)、地域シェア、動向、成長機会 - 分析範囲 (製品種類別、国別)
出版日: 2024年12月20日
発行: The Insight Partners
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の経腸栄養の市場規模は、2023年の33億2,000万米ドルから2031年には57億9,000万米ドルに達すると予測されています。2023～2031年のCAGRは7.2%と予測されています。

標準化された処方と植物ベースの栄養製品

消費者の積極的な健康管理を支援する製品、特にエネルギーレベル、免疫力、疾病治療といった特定のニーズに焦点を当てた製品に対する需要が急増しています。経腸製品の機能性と特殊な製剤は、患者の既存の治療を妨げることはありません。経腸栄養の大栄養素および微量栄養素の処方とその用途は、対象となる疾患によって異なります。等カロリー経腸栄養製剤 (1kcal/ml) は一般に、推定または測定されたカロリー目標を達成するために処方されますが、エネルギー密度の高い製剤 (>1kcal/ml) は、胃腸機能障害のある患者へのカロリー供給を増加させるために処方されます。

標準化された経腸栄養製品は、固定成分を含み、年齢層によって要求量が異なることを考慮して、患者の平均的な栄養要求量を満たすように設計されています。例えば、ペプタメンフォーミュラ (ネスレ) は、酵素的に加水分解された100%乳清タンパク質を含む唯一のペプチドベースのミルクであり、経管栄養の不耐性を克服するのに役立ちます。このような経管栄養剤は、胃腸障害のある人の吸収をサポートし、耐性メカニズムを克服するために設計された特殊な経腸栄養製品です。

植物性食品に目を向ける人々の急増が、植物性栄養製品に対する世界の需要の引き金となっています。人々は、副作用につながる可能性のある、より多く使用される人工的／合成的な原材料にますます不寛容になりつつあります。Innova Consumer Survey 2020によると、健康、食事の多様性、持続可能性、味が、人々が植物由来の代替食品を検討する理由の上位に挙げられています。アボット社によれば、経管栄養に頼る消費者や患者も、これらのパラメータに大きな関心を寄せています。欧州の経腸栄養市場の企業は、さまざまな層で健康的な食品への嗜好が高まっていることを利用しています。その結果、Kate Farms社、Functional Formularies社、Real Food Blends社などの企業が、より自然で植物ベースの経腸製品を開発しています。2021年8月、ケイト・ファームズは、植物由来のフォーミュラを容量1Lのすぐに吊り下げられる袋に入れた初の閉鎖式栄養補給システムを発売しました。Kate Farms Standard 1.4プレーンおよびPeptide 1.5プレーン製剤は、植物由来のオーガニックでカロリーの高い製品で、経管栄養における唯一の補助栄養源として使用されます。2021年9月、アボット社は小児および成人用の植物性タンパク質および有機食品素材のポートフォリオを発表しました。

したがって、機能的で患者中心の処方と植物ベースの栄養製品は、欧州経腸栄養市場の主要な新興動向です。

フランスの経腸栄養市場分析

2023年3月に発表されたルモンド紙の記事によると、フランスでは60歳以上の人口比率が2023年の～20%から2050年には～30%に急増すると予想されています。85歳以上の人口は、2030年から2050年にかけて90%近く増加します。高齢者は、糖尿病、心血管疾患、神経疾患 (脳卒中、パーキンソン病、アルツハイマー病など) といった慢性疾患を患っていることが多いです。これらの疾患は正常な食事能力を損ない、栄養失調を引き起こし、経腸栄養を必要とします。Global Cancer Observatoryによると、フランスでは2022年に483,568人の新規がん患者が報告され、有病者数 (5年間) は1,494,814人でした。がんと経腸栄養は密接な関係にあります。がん患者の多くは、病気そのものや治療が原因で栄養失調に陥り、必要な栄養素を食べたり吸収したりする能力が損なわれています。

フレゼニウス・カビール・フランスは、経管栄養、経口栄養補助食品 (ONS)、粉末製品など、すぐに使用できる経腸栄養製品の多様なポートフォリオを提供しています。嚥下障害のある患者向けに、同社はさまざまな患者の個別ニーズに対応するため、さまざまな組成のテクスチャー改良製品を提供しています。

欧州経腸栄養市場レポートセグメンテーション分析

欧州経腸栄養市場分析の導出に寄与した主要セグメントは、タイプ、材料、エンドユーザーです。

製品タイプに基づき、欧州の経腸栄養市場は経鼻胃、経鼻経腸、シッピング、その他にセグメント化されます。経鼻胃管セグメントは2023年に市場で最大のシェアを占めました。

欧州経腸栄養市場で事業を展開している著名な企業は、Nestle、Danone S.A.、Abbott Laboratories、Friesland Campina、Fresenius SE and Co.KGaA、B. Braun SE、Dr. Schar AG、Arla Food、Reckitt Benckiser、Perrigo Company PLC、Fonterra Co-operative Group Limited、Kate Farms、Nutritional Medicinals, LLCなどです。

各社は、欧州の経腸栄養の市場規模での地位を維持するために、新しく革新的な製品やサービスを発表しています。2021年11月、アボット社は免疫系、消化器の健康、脳の開発をサポートするシミラック360トータルケアを発売しました。シミラック 360トータルケアは、これまで母乳にしか含まれていなかった5種類のHMOをブレンドした米国初で唯一の乳児用調製粉乳です。この粉ミルクは、発育中の免疫系、消化器系、脳を含む赤ちゃんの健康と発育全体をサポートする栄養を提供するように設計されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 分析手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 欧州の経腸栄養市場の情勢

  • PEST分析
  • 価格分析
  • シッピングフォーミュラの価格分析
  • 上位5市場の主要企業リスト
    • ドイツ、フランス、英国の主要企業

第5章 欧州の経腸栄養市場：主な市場力学

  • 欧州経腸栄養市場：主要市場力学
  • 市場促進要因
    • 胃腸疾患の有病率の増加
    • 栄養不良および早産事例の増加
  • 市場抑制要因
    • 栄養補給システムに伴う機械的、胃腸的、代謝的合併症
  • 市場機会
    • 主要企業の戦略的取り組み
  • 今後の動向
    • 標準化された処方と植物ベースの栄養製品
  • 促進要因と抑制要因の影響

第6章 欧州の経腸栄養市場分析

  • 欧州の経腸栄養市場の収益 (2021～2031年)
  • 欧州の経腸栄養市場の予測と分析
  • 経腸および非経口栄養の市場規模 (金額ベース、%)

第7章 欧州の経腸栄養市場の分析：製品種類別

  • 経鼻胃
  • 経鼻腸管
  • シッピング (Sipping)
  • その他

第8章 欧州経腸栄養市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • チェコ
    • その他欧州

第9章 業界情勢

  • 欧州経腸栄養市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第10章 企業プロファイル

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Kate Farms Inc
  • Dr Schar AG
  • Fonterra Co-Operative Group Ltd
  • Arla Foods amba
  • Perrigo Co Plc
  • Charing Cross Scientific AS
  • Bexen Medical

第11章 付録

図表

List Of Tables

  • Table 1. Europe Enteral Nutrition Market Segmentation
  • Table 2. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
  • Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
  • Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
  • Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
  • Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
  • Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
  • Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
  • Table 11. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 12. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 14. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 15. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 16. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 17. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 18. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 19. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 20. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 21. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 22. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 23. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 24. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 25. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 26. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 27. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 28. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 29. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 30. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 31. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 32. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 33. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 34. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 35. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 36. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 37. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 38. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 39. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 40. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 41. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 42. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 43. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 44. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 45. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 46. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 47. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 48. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 49. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 50. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 51. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 52. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 53. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 54. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 55. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 56. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 57. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 58. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 59. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 60. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
  • Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
  • Table 63. Glossary of Terms, Europe Enteral Nutrition Market

List Of Figures

  • Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Enteral Nutrition Market Share (%) - by Product Type, 2023 and 2031
  • Figure 6. Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Europe Enteral Nutrition Market
目次
Product Code: TIPRE00039375

The Europe enteral nutrition market size is projected to reach US$ 5.79 billion by 2031 from US$ 3.32 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023-2031.

Standardized Formulations and Plant-Based Nutrition Products

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet the average nutritional requirements of patients, considering that the requirements differ in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tube feeding also pay much attention to these parameters. Companies in the Europe enteral nutrition market are capitalizing on the growing preference for healthy foods in various demographic groups. As a result, companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the Europe enteral nutrition market.

France Enteral Nutrition Market Analysis

According to a Le Monde article published in March 2023, the population share of people aged 60 or more in France is expected to surge from ~20% in 2023 to ~30% by 2050. The number of people aged 85 and above would grow by nearly 90% during 2030-2050. Older adults often experience chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders (e.g., stroke, Parkinson's disease, and Alzheimer's). These conditions can impair the ability to eat normally, leading to malnutrition and requiring enteral feeding. According to the Global Cancer Observatory, France reported 483,568 new cancer cases in 2022, and the number of prevalent cases (5-year) was 1,494,814. Cancer and enteral nutrition are closely connected. Many cancer patients suffer from malnutrition due to the disease itself or the treatments they receive, which can impair their ability to eat and absorb essential nutrients.

Fresenius Kabir France offers a diverse portfolio of ready-to-use enteral nutrition products such as tube feeds, oral nutritional supplements (ONS), and powder products. For patients with dysphagia, the company offers texture-modified products in different consistencies to meet the individual needs of different patients.

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Europe enteral nutrition market analysis are type, material, and end user.

Based on product type, the Europe enteral nutrition market is segmented into Nasogastric, Nasoenteral, Sipping and Others. The nasogastric segment held the largest share of the market in 2023.

A few prominent players operating in the Europe enteral nutrition market are Nestle, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the Europe enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby's health and development, including the developing immune system, digestive system, and brain.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Enteral Nutrition Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
  • 4.4 Pricing Analysis for Sipping Formula
  • 4.5 List of Key Market Players in Top 5 Market
    • 4.5.1 Major Market players in Germany, France, United Kingdom

5. Europe Enteral Nutrition Market - Key Market Dynamics

  • 5.1 Europe Enteral Nutrition Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
    • 5.2.2 Rising Cases of Malnutrition and Premature Births
  • 5.3 Market Restraints
    • 5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Key Market Players
  • 5.5 Future Trends
    • 5.5.1 Standardized Formulations and Plant-Based Nutrition Products
  • 5.6 Impact of Drivers and Restraints:

6. Europe Enteral Nutrition Market Analysis

  • 6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Enteral Nutrition Market Forecast and Analysis
  • 6.3 Enteral and Parenteral Market Value (%)

7. Europe Enteral Nutrition Market Analysis - by Product Type

  • 7.1 Nasogastric
    • 7.1.1 Overview
    • 7.1.2 Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.3 Standard
      • 7.1.3.1 Overview
      • 7.1.3.2 Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.4 Disease Specific
      • 7.1.4.1 Overview
      • 7.1.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Nasoenteral
    • 7.2.1 Overview
    • 7.2.2 Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Sipping
    • 7.3.1 Overview
    • 7.3.2 Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Enteral Nutrition Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
    • 8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.2 Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.3 United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.4 France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.5 Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.6 Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.7 Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Europe Enteral Nutrition Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Nestle SA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Danone SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Abbott Laboratories
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Royal FrieslandCampina NV
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Fresenius SE & Co KGaA
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Reckitt Benckiser Group Plc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Kate Farms Inc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Dr Schar AG
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Fonterra Co-Operative Group Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Arla Foods amba
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments
  • 10.12 Perrigo Co Plc
    • 10.12.1 Key Facts
    • 10.12.2 Business Description
    • 10.12.3 Products and Services
    • 10.12.4 Financial Overview
    • 10.12.5 SWOT Analysis
    • 10.12.6 Key Developments
  • 10.13 Charing Cross Scientific AS
    • 10.13.1 Key Facts
    • 10.13.2 Business Description
    • 10.13.3 Products and Services
    • 10.13.4 Financial Overview
    • 10.13.5 SWOT Analysis
    • 10.13.6 Key Developments
  • 10.14 Bexen Medical
    • 10.14.1 Key Facts
    • 10.14.2 Business Description
    • 10.14.3 Products and Services
    • 10.14.4 Financial Overview
    • 10.14.5 SWOT Analysis
    • 10.14.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms